The Saskatchewan Multiple Sclerosis (MS) Drugs Research Program aids to study the use of MS disease-modifying medications by people living with MS in Saskatchewan.
Anyone with a diagnosis of MS may volunteer to participate, even if they have never taken a disease-modifying medication.
The research also studies the relationships between MS drug treatment, quality of life, physical activity, and other health outcomes in order to continuously improve the quality of MS care.
This long-term research program was established in 1998 by Dr. Walter Hader at the University of Saskatchewan. The program is currently led by Dr. Katherine Knox and is funded by the Saskatchewan Ministry of Health.
Saskatchewan MS Drugs Research Program Newsletters
Contact the Program
To learn more about this research or to find information about MS and MS drugs in Saskatchewan, contact the Saskatchewan MS Drugs Research Program staff